Aaron James Pearce
Analyst · Bank of America. Your line is open
Thank you, Michael. Good morning, everyone. I'll start the financial review on Slide number 3. Sales in the fourth quarter were $306.1 million which was an increase of 21.6% compared to the same quarter last year. GAAP pretax earnings were $41.6 million which was an increase of 19.4% when compared to Q4 of last year. Non-GAAP pretax income was $45.4 million which was an increase of 30% when compared to Q4 of last year. The only adjustment to arrive at non-GAAP pretax income is the removal of truly nonrecurring costs, such as acquisition-related legal fees, tax fees and accounting fees as well as the financial impact from recording inventories at fair value. GAAP diluted EPS finished at $0.53, while non-GAAP EPS increased 32% to $0.70 this quarter. The only adjustments to arrive at non-GAAP EPS were the removal of the acquisition costs that I just mentioned, removal of a nonrecurring tax charge related to one of the acquisitions and the removal of an impairment charge related to an equity method investment. We also had another very strong quarter of cash generation. Cash provided by operating activities was $50.8 million which was 12.6% higher than the $45.1 million of operating cash flow generated in the fourth quarter of last year. So financially, Q4 was a very strong quarter. Moving to Slide number 4, you'll find our quarterly sales trends. Our plus 20% sales increase consisted of organic sales growth of 12.6%, an increase from acquisitions of 4.7% and an increase from foreign currency translation of 4.3%. Organic sales continued to improve in our ID Solutions business and finished up a robust 24.5% in Q4. Our Workplace Safety business benefited from strong COVID-related product sales in last year's fourth quarter. As a result of these tough comparables, we saw a decline in WPS organic sales of 12.7%. However, we remain quite optimistic about the future of our WPS business as we've increased our customer base, improved our digital presence and have many new proprietary products, all of which bode well for the future. Turning to Slide number 5, you'll see our gross profit margin trending. Our gross profit margin increased by 110 basis points this quarter, finishing at 48.2% compared to 47.1% in the fourth quarter of last year. If you exclude the purchase accounting charges from our recent acquisitions, our gross profit margin would have been approximately 20 basis points higher than the reported GAAP figures. The improvement over the fourth quarter of last year was a direct result of increased sales volumes and many efficiency activities that we've been driving throughout our manufacturing facilities. As you would expect, we are seeing inflationary pressures in raw materials, freight and certain services. We're also seeing wage inflation and we're finding it difficult to fill open manufacturing roles. But we're automating wherever we can, we're driving efficiencies at a strong pace and we're putting through targeted price increases. We believe that these actions will offset any inflationary forces and enable us to maintain our gross profit margin in the approximate 50% range. On Slide number 6, you'll find our SG&A expense trending. SG&A was $93.7 million this quarter compared to $75.9 million in the fourth quarter of last year. SG&A was heavily impacted by both the recent acquisitions as well as an increase in incentive-based compensation. Last year, as a result of the pandemic, our incentive-based compensation was down significantly. In fact, in the fourth quarter of last year, our incentive comp was negative, whereas this year, incentive-based comp is running at more normalized levels. And as a percent of sales, SG&A was 30.6% this quarter. If you'd exclude the nonrecurring costs that I mentioned earlier, SG&A would have been below 30% of sales this quarter which would have continued the general trend of declining SG&A as a percent of sales even as we're increasing investments in sales and marketing to accelerate sales growth. Moving on to Slide number 7, you'll find the trending of our investments in Research and Development. This quarter, we invested $13.2 million in R&D. Approximately $1.3 million of R&D expense came from our three fourth quarter acquisitions. We continue to have opportunities to invest in new product development and we're committed to increasing these investments, while at the same time, ensuring that we get the most out of every dollar spent on R&D. These investments in R&D are critical to help propel Brady's long-term sales growth and protect our gross profit margins. Slide number 8 illustrates our pretax income trends. Non-GAAP pretax earnings increased 30% from $34.9 million last year to $45.4 million this quarter. Again, the only items we're adjusting for to get to non-GAAP pretax earnings are the truly nonrecurring costs related to our recently completed acquisitions. This 30% increase in pretax earnings was a direct result of our very strong sales growth, combined with our ongoing focus on automation and sustainable efficiency gains. Slide number 9 illustrates our after-tax income and EPS trends. As I mentioned, non-GAAP diluted EPS was $0.70 this quarter compared to $0.53 in last year's fourth quarter, an increase of 32%. On Slide number 10, you'll find a summary of our cash generation which continues to be quite strong. We generated $50.8 million of cash flow from operating activities and free cash flow was $45 million this quarter. The conversion of net income into operating cash flow was once again very strong with operating cash flow well in excess of both GAAP and non-GAAP net income. Now if you'll turn to Slide number 11, you can see the impact that the strong cash generation is having on our balance sheet. Even after using $244 million of cash for the acquisitions of Magicard, Nordic ID and Code, on July 31, we were still in a net cash position of $109.3 million. Our strong balance sheet puts us in a fantastic position to execute additional value-enhancing activities, including investing in R&D, completing additional acquisitions and returning funds to our shareholders. Our approach to capital allocation is consistent. First, we use our cash to fully fund organic sales and efficiency opportunities throughout the economic cycle. We're funding investments in new product development, sales generating resources, IT improvements, capability enhancing CapEx and CapEx to further automate our facilities. We will absolutely keep funding these investments where it makes sense and where the investments are ROI positive. And second, we focus on returning cash to our shareholders in the form of dividends. And as we just announced last night, we're increasing our annual dividend for the 36th consecutive year. After funding organic investments and dividends, we then deploy our cash in a disciplined manner for either buybacks or acquisitions where we believe that we have strong synergistic opportunities. Slide number 12 provides an overview of our financial results for the full year ended July 31, 2021. Overall, sales increased 5.9% and we finished with all-time record earnings per share. Of course, both our revenues and our earnings were significantly impacted by the COVID-19 pandemic throughout most of fiscal 2021 which makes these record EPS results all that much more impressive. Plus, we're exiting fiscal '21 with positive momentum. Q4 was our strongest revenue quarter of the year with IDS posting organic sales growth of 24.5% and WPS running at a sales rate higher than what we experienced prior to the pandemic. Plus, the acquisitions we completed in the fourth quarter should provide positive momentum as we move into fiscal 2022. With that, let's move to our outlook for this upcoming fiscal year which is on Slide number 13. We're forecasting diluted earnings per share, excluding amortization to range from $3.12 to $3.32 per share. which equates to a GAAP EPS range of $2.90 to $3.10 per share for the fiscal year ending July 31, 2022. This implies that we expect GAAP EPS to improve somewhere in the range of 17.4% to 25.5% in fiscal 2022. And if you exclude the impact of amortization expense which increases significantly as a result of our three fourth quarter acquisitions, then our EPS would increase from 21% to 29%. Included in our earnings per share guidance is an increase in after-tax amortization expense from our recent acquisitions of approximately $6 million. After-tax amortization is increasing from about $5.5 million in fiscal 2021 to about $11.5 million in fiscal '22 which is a delta of about $0.12 per share. As we look at phasing throughout the upcoming fiscal year, we expect the majority of our EPS growth to come in the second half of the fiscal year and we also expect that our Workplace Safety business will experience a decline in organic sales in the first quarter of this year due to the strong prior year comparables, driven by COVID-related product sales last year. We are also anticipating total sales growth in excess of 12% for the year ending July 31, 2022 which is inclusive of both organic sales growth as well as sales from the recently completed acquisitions. This guidance is based on foreign currency exchange rates as of July 31, 2021 and is, of course, contingent upon continued macroeconomic expansion. We'll continue to make the investments necessary to drive organic sales growth. We'll continue to search for acquisitions that advance our strategies and we will continue to drive sustainable efficiency gains while being tight on nonrevenue-generating expenses. As for capital allocation, we do not foresee any major changes in our capital allocation strategy. We will keep investing in our organic business. I just mentioned our dividend increase for fiscal 2022 and we'll be opportunistic with buybacks while looking for acquisitions where the price is right and the strategic fit is clear. We have a strong balance sheet and we'll use it as a tool to drive long-term shareholder value. I'll now turn the call back over to Michael to cover our divisional results and to provide some closing comments before the Q&A session. Michael?